Bcl-2 family proteins and leukemia. Minireview

J Kusenda1

  • 1Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia.

Neoplasma
|August 26, 1998
PubMed

Insights

Bcl-2 proteins inhibit apoptosis, a key process in cancer. Dysregulated Bcl-2 expression is linked to leukemia and lymphoma development and chemoresistance.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • The Bcl-2 protein family plays a critical role in regulating programmed cell death (apoptosis).
  • Dysregulation of Bcl-2 family proteins is implicated in the pathogenesis of various cancers, particularly hematological malignancies.
  • Understanding the mechanisms of Bcl-2 action is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To review the current understanding of Bcl-2 family protein functions.
  • To explore the emerging mechanisms by which these proteins suppress cell death.
  • To highlight the role of Bcl-2 family proteins in leukemia and lymphoma.

Main Methods:

  • Literature review of existing research on Bcl-2 family proteins.
  • Analysis of studies investigating the role of Bcl-2 in apoptosis regulation.
  • Examination of data linking Bcl-2 expression to leukemia and lymphoma.

Main Results:

  • Bcl-2 proteins function as oncogenes by inhibiting apoptosis.
  • Emerging evidence suggests a dual role for Bcl-2 family proteins, potentially involving mitochondrial membrane channel activity and adaptor protein functions.
  • Interactions between Bcl-2 and other proteins are hypothesized to contribute to their function.
  • Dysregulated Bcl-2 expression is associated with the pathogenesis and prognosis of certain leukemias and lymphomas.
  • Bcl-2 family proteins represent a novel mechanism of chemoresistance in cancer.

Conclusions:

  • Bcl-2 family proteins are critical regulators of apoptosis.
  • Their dysregulated expression significantly impacts leukemia and lymphoma.
  • These proteins offer potential therapeutic targets for overcoming chemoresistance in cancer.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...